Suppr超能文献

由间接呈递引发的细胞毒性T淋巴细胞识别的免疫显性次要组织相容性抗原肽。

Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.

作者信息

Nevala W K, Paul C, Wettstein P J

机构信息

Department of Surgery, The Mayo Foundation, Rochester, Minnesota 55905, USA.

出版信息

Transplantation. 1998 Feb 27;65(4):559-69. doi: 10.1097/00007890-199802270-00018.

Abstract

BACKGROUND

Indirect presentation of minor histocompatibility antigens (HA) as revealed by cross-priming of H2 heterozygous recipients effectively primes minor HA-specific cytolytic T lymphocytes (CTLs). However, it is not known if indirect priming generates CTLs specific for the same set of immunodominant minor HA recognized by CTLs primed by direct spleen cell injections.

METHODS

In order to indirectly prime minor HA-specific CTLs, we implanted (C57BL/6 x B6.C-H2d)F1 recipients with BALB.B and BALB/c splenocytes loaded into immunoisolation devices that effectively preclude direct donor:host contact. Responder spleen cells from these recipients were stimulated in vitro to expand BALB.B- and BALB/c-specific CTLs to reveal classical cross-priming.

RESULTS

Tests of CTL specificity using (1) CXB recombinant inbred strain targets that express different arrays of BALB/c minor HA and (2) high-performance liquid chromatography fractions of peptides from BALB.B Kb and Db molecules revealed that anti-BALB.B CTLs were specific for two previously identified dominant peptides, CTT-2 and CTT-5, presented by Kb molecules. Variation of responders and priming cells resulted in CTL responses to additional dominant peptides that had been identified previously with CTLs generated by direct priming with spleen cell injections. Indirect priming was not limited to this set of peptides recognized by CTLs in vitro because devices loaded with cells devoid of the CTL-detected peptides primed for accelerated skin allograft rejection.

CONCLUSIONS

Indirect presentation of minor HA in vivo stimulates the generation of CTLs specific for a subset of dominant minor HA peptides recognized by CTLs primed by direct presentation.

摘要

背景

通过对H2杂合受体进行交叉致敏所揭示的次要组织相容性抗原(HA)的间接呈递可有效激活次要HA特异性细胞毒性T淋巴细胞(CTL)。然而,尚不清楚间接致敏所产生的CTL是否针对与直接注射脾细胞致敏所产生的CTL所识别的同一组免疫显性次要HA具有特异性。

方法

为了间接致敏次要HA特异性CTL,我们将装载于免疫隔离装置中的BALB.B和BALB/c脾细胞植入(C57BL/6×B6.C-H2d)F1受体,该装置可有效防止供体与宿主直接接触。来自这些受体的反应性脾细胞在体外受到刺激,以扩增BALB.B和BALB/c特异性CTL,以揭示经典的交叉致敏。

结果

使用(1)表达不同BALB/c次要HA阵列的CXB重组近交系靶标和(2)来自BALB.B Kb和Db分子的肽的高效液相色谱馏分对CTL特异性进行测试,结果显示抗BALB.B CTL对由Kb分子呈递的两种先前鉴定的显性肽CTT-2和CTT-5具有特异性。反应者和致敏细胞的变化导致CTL对其他显性肽产生反应,这些显性肽先前已通过脾细胞注射直接致敏所产生的CTL鉴定出来。间接致敏不限于体外CTL所识别的这组肽,因为装载有无CTL检测到的肽的细胞的装置可引发加速的皮肤同种异体移植排斥反应。

结论

体内次要HA的间接呈递刺激产生针对直接呈递致敏所产生的CTL所识别的一部分显性次要HA肽具有特异性的CTL。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验